Assessing Knowledge, Attitudes, and Perceptions of Personalized Risk-Stratified Cervical Cancer Screening among Indian Women Using The COM-B Framework: A Mixed-Methods Study

Cervical cancer is a disease that begins in the neck of the womb, and it stands as one of the most common causes of cancer death among women in India. The tragedy of this disease lies not in its inevitability, but in its preventability. Medical science has long known that this cancer can be stopped before it ever becomes dangerous through vaccination or by finding early warning signs through screening. Screening involves simple tests that look for changes in the cells of the cervix, often before a woman feels any sickness at all. Yet, despite the existence of these life-saving tools, many women in India never receive them. The gap between what is possible and what happens is not just about a lack of clinics or money; it is deeply rooted in what people know, what they fear, and how their daily lives allow or block them from seeking care. To understand why women do or do not get screened, researchers are increasingly looking at behavior not as a simple choice, but as the result of three things working together: whether a person has the knowledge and ability to act, whether the world around them makes it possible to act, and whether they feel motivated to take that step.

A team of researchers set out to explore these exact barriers among women in and around Hyderabad, India. They wanted to understand why the uptake of screening remains so low, even as new, smarter ways to screen—called personalized risk-stratified screening—begin to emerge. Unlike the old method where every woman gets tested on the same schedule, this new approach tailors how often a woman is tested based on her specific risk factors, such as her age and whether she carries a virus known to cause the disease. The researchers asked a simple but difficult question: would Indian women be willing to participate in this more personalized system, and what would stop them from doing so? To find the answer, they spoke with 430 women between the ages of 18 and 60. They asked them direct questions about what they knew and how they felt, and they also held deeper conversations with a smaller group to hear the stories behind the numbers.

The results revealed a landscape where hope is often blocked by confusion and fear. When the researchers asked the women if they knew that cervical cancer could be prevented, only about one in three said yes. Fewer than half could name the main risk factors, and only about one in five had ever undergone a screening test. The women who had never been screened often did not realize that the tests were meant for healthy women who felt fine. Many believed that if they had no symptoms, there was no need to visit a doctor. This lack of knowledge was compounded by a deep-seated anxiety. For many, the idea of a pelvic examination was terrifying. They feared pain, bleeding, or the possibility of being told they had cancer, a thought that felt so overwhelming that it kept them away from the clinic entirely. There was also a heavy social weight; in many families and communities, discussing reproductive health or the virus that causes the disease was considered shameful. Women worried that if they were tested, their neighbors or even their own families might judge them, or that a positive result would damage their relationships.

Despite these hurdles, the study found that the desire to be screened was actually quite strong, provided the right conditions were met. The women did not reject the idea of personalized screening; in fact, many saw it as a way to avoid unnecessary visits if their risk was low. However, they needed to feel safe and supported. The most powerful factor that made a woman willing to go for a test was a direct recommendation from a doctor. When a physician explained the process and the importance of the test, the fear often receded. Money and privacy were equally critical. Women said they would participate if the test was free and if they could be examined in a private room by a female doctor. They were hesitant about crowded government hospitals where they might have to wait for hours or be examined in front of others. The researchers found that when these structural barriers were removed—when the cost was zero, the privacy was assured, and a trusted doctor gave the advice—willingness to participate rose significantly.

The study suggests that the solution to low screening rates is not just to build more clinics or hand out more pamphlets. It requires a shift in how the system interacts with the woman. The researchers concluded that a successful program must address the whole picture: it must educate women so they understand that screening is for prevention, not just for the sick; it must create an environment where women feel physically comfortable and socially safe; and it must rely on the trust that women place in their doctors. The personalized approach of testing women based on their specific risk could be a powerful tool, but only if it is delivered with the same care and attention to human emotion that the women themselves described. Without addressing the fear, the cost, and the cultural silence, even the most advanced medical strategy will struggle to reach the women who need it most. The path forward, the data shows, is to make screening not just a medical procedure, but a supported, accessible, and dignified experience.